Globally recognised Australian biotech company, TGR BioSciences, has today announced the award of its fourth US Patent, covering extended aspects of its innovative CaptSure™ immunoassay technology, known to be faster and more sensitive than its competitors.
This fourth US Patent (9,778,252) follows three recently acquired US Patents (9,261,500 in 2016, 9,086,407 in 2015, and 9,476,874 in January 2017) granted to TGR BioSciences’ CaptSure™ technology, which has a wide range of potential applications, from clinical diagnostics to the detection of plant diseases.
The US Patent specifically encapsulates the application of TGR’s CaptSure™ technology, which is a revolutionary antibody immobilization system, to TGR’s SureFire Ultra bead-based detection system.
Chief Scientific Officer at TGR, Dr Antony Sheehan, said that the granting of this patent will secure TGR’s intellectual property surrounding SureFire Ultra, and as such, will provide greater opportunities for expanding the application of the technology globally.
“The addition of CaptSure™ technology to our SureFire Ultra assay system will greatly enhance capabilities for our clients to develop new drugs for curing disease,” Dr Sheehan said.
“We expect the granting of this US Patent to further encourage the use of this technology across many fields.
“The use of SureFire Ultra with CaptSure™ in both research and development, as well as drug development programs around the world is expanding, and so directly contributing to the global effort for improving health outcomes.”
CaptSure™ technology is adaptable to a variety of testing formats, including: ELISA, beads and lateral flow. It provides greatly reduced manufacturing costs and rapid product development times and this US Patent consolidates TGR’s position as major player in the international biotechnology industry.
Established in 2001, TGR BioSciences Pty Ltd (TGR) is a private company located in Adelaide, Australia. TGR provides innovative solutions for biological research applications, with expertise in cell biology, biochemistry and immunoassay design. TGR’s high quality products have been used successfully in drug discovery programs around the world.